BACKGROUND: Obesity is related to a higher rate of infections and some types of cancer. Here we analyzed the impact of obesity and weight loss induced by Roux-en-Y gastric bypass (RYGB) on immunological parameters, i.e., cytokine productions and natural killer cell function. METHODS: We analyzed 28 morbidly obese patients before and 6 months after RYGB. Biochemical parameters were analyzed in plasma. The percent of natural killer (NK) cells, their cytotoxicity, and the production of cytokines by peripheral blood mononuclear cells were analyzed. The percent of NK cells was determined by flow cytometry and cytokine production determined by enzyme-linked immunosorbent assay. NK cytotoxicity was determined by the lactate dehydrogenase release assay. RESULTS: The weight loss 6 months following surgery was 35.3 ± 4.5 kg. RYGB also improves biochemical parameters. No significant difference was found in the percent of NK cells after surgery. We found an increase in the production of interferon-γ, interleukin (IL)-12 and IL-18, but not in IL-2, 6 months after RYGB. Cytotoxic activity of NK cells was significantly enhanced 6 months after RYGB [17.1 ± 14.7% before RYGB vs 51.8 ± 11.3% at 6 months after, at 40:1 effector to target cell ratio; p < 0.001]. We observed significant post-surgical improvement in the cytotoxic activity curve in 22 out of 28 patients (78.6%), irrespective of the target to effector cell ratio. CONCLUSIONS: The weight loss induced by RYGB modifies the production of cytokines related with NK cell function and improves its activity.
BACKGROUND:Obesity is related to a higher rate of infections and some types of cancer. Here we analyzed the impact of obesity and weight loss induced by Roux-en-Y gastric bypass (RYGB) on immunological parameters, i.e., cytokine productions and natural killer cell function. METHODS: We analyzed 28 morbidly obesepatients before and 6 months after RYGB. Biochemical parameters were analyzed in plasma. The percent of natural killer (NK) cells, their cytotoxicity, and the production of cytokines by peripheral blood mononuclear cells were analyzed. The percent of NK cells was determined by flow cytometry and cytokine production determined by enzyme-linked immunosorbent assay. NK cytotoxicity was determined by the lactate dehydrogenase release assay. RESULTS: The weight loss 6 months following surgery was 35.3 ± 4.5 kg. RYGB also improves biochemical parameters. No significant difference was found in the percent of NK cells after surgery. We found an increase in the production of interferon-γ, interleukin (IL)-12 and IL-18, but not in IL-2, 6 months after RYGB. Cytotoxic activity of NK cells was significantly enhanced 6 months after RYGB [17.1 ± 14.7% before RYGB vs 51.8 ± 11.3% at 6 months after, at 40:1 effector to target cell ratio; p < 0.001]. We observed significant post-surgical improvement in the cytotoxic activity curve in 22 out of 28 patients (78.6%), irrespective of the target to effector cell ratio. CONCLUSIONS: The weight loss induced by RYGB modifies the production of cytokines related with NK cell function and improves its activity.
Authors: Melinda A Maggard; Lisa R Shugarman; Marika Suttorp; Margaret Maglione; Harvey J Sugerman; Harvey J Sugarman; Edward H Livingston; Ninh T Nguyen; Zhaoping Li; Walter A Mojica; Lara Hilton; Shannon Rhodes; Sally C Morton; Paul G Shekelle Journal: Ann Intern Med Date: 2005-04-05 Impact factor: 25.391
Authors: Efstathios V Kotidis; George G Koliakos; Vasilios G Baltzopoulos; Konstantinos N Ioannidis; John G Yovos; Spiros T Papavramidis Journal: Obes Surg Date: 2006-11 Impact factor: 4.129
Authors: Laura M Tobin; Meenal Mavinkurve; Eirin Carolan; David Kinlen; Eoin C O'Brien; Mark A Little; David K Finlay; Declan Cody; Andrew E Hogan; Donal O'Shea Journal: JCI Insight Date: 2017-12-21
Authors: A E Hogan; A M Tobin; T Ahern; M A Corrigan; G Gaoatswe; R Jackson; V O'Reilly; L Lynch; D G Doherty; P N Moynagh; B Kirby; J O'Connell; D O'Shea Journal: Diabetologia Date: 2011-07-09 Impact factor: 10.122
Authors: Soheila Shakeri-Leidenmühler; Anna Lukschal; Cornelia Schultz; Arthur Bohdjalian; Felix Langer; Tudor Birsan; Susanne C Diesner; Elli K Greisenegger; Otto Scheiner; Tamara Kopp; Erika Jensen-Jarolim; Gerhard Prager; Eva Untersmayr Journal: Obes Surg Date: 2015-12 Impact factor: 4.129
Authors: Esraa Elaraby; Abdullah Imadeddin Malek; Hanan W Abdullah; Noha Mousaad Elemam; Maha Saber-Ayad; Iman M Talaat Journal: J Immunol Res Date: 2021-06-07 Impact factor: 4.818